Skip to content
2000
Volume 20, Issue 1
  • ISSN: 1573-4056
  • E-ISSN: 1875-6603
side by side viewer icon HTML

Abstract

Introduction/Background

The COVID-19 pandemic has resulted in a large number of deaths and has caused a significant increase in population morbidity. This viral infection has been associated with different neurological symptoms and complications that do not have a clear pathophysiological mechanism and exact implications for these patients.

Case Presentation

A 40-year-old man with COVID-19 and co-infection with KPC presented extensive pulmonary involvement and required comprehensive management in the intensive care unit (ICU). During his hospitalization, he developed neurological symptoms with evidence of involvement of the corpus callosum, which was attributed to the cytotoxic lesion of the corpus callosum (CLOCC). After several months of interdisciplinary management in the ICU, there was a progressive improvement in his general condition, with discharge from the hospital without significant sequelae, with follow-up images showing complete involvement of the corpus callosum due to what was considered an atypical cytotoxic lesion of the corpus callosum.

Conclusion

Imaging features of CLOCCs are known to be temporary, but in the setting of COVID-19, it has not yet been determined if this is true and further studies are needed. Nonetheless, the one-year follow-up of our patient makes us believe that this atypical involvement of the corpus callosum described in severe SARS-CoV-2 infections is not transitory, even if there are no neurologic sequelae.

© 2024 The Author(s). Published by Bentham Open. This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/cmir/10.2174/1573405620666230414110124
2024-01-01
2024-11-23
Loading full text...

Full text loading...

/deliver/fulltext/cmir/20/1/CMIM-20-e140423215809.html?itemId=/content/journals/cmir/10.2174/1573405620666230414110124&mimeType=html&fmt=ahah

References

  1. Geneva S. World Health Organization. Coronavirus disease 2019 (COVID-19) situation report – 1102019Available from: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---21-september-2022
  2. KlironomosS. TzortzakakisA. KitsA. ÖhbergC. KolliaE. AhoromazdaeA. AlmqvistH. AspelinÅ. MartinH. OuelletteR. Al-SaadiJ. HasselbergM. HaghgouM. PedersenM. PeterssonS. FinnssonJ. LundbergJ. Falk DelgadoA. GranbergT. Nervous system involvement in coronavirus disease 2019: Results from a retrospective consecutive neuroimaging cohort.Radiology20202973E324E33410.1148/radiol.202020279132729812
    [Google Scholar]
  3. GuerreroJ.I. BarragánL.A. MartínezJ.D. MontoyaJ.P. PeñaA. SobrinoF.E. Tovar-SpinozaZ. GhotmeK.A. Central and peripheral nervous system involvement by COVID-19: A systematic review of the pathophysiology, clinical manifestations, neuropathology, neuroimaging, electrophysiology, and cerebrospinal fluid findings.BMC Infect. Dis.202121151510.1186/s12879‑021‑06185‑634078305
    [Google Scholar]
  4. RasmussenC. NiculescuI. PatelS. KrishnanA. COVID-19 and involvement of the corpus callosum: Potential effect of the cytokine storm?AJNR Am. J. Neuroradiol.20204191625162810.3174/ajnr.A668032732269
    [Google Scholar]
  5. StarkeyJ. KobayashiN. NumaguchiY. MoritaniT. Cytotoxic lesions of the corpus callosum that show restricted diffusion: Mechanisms, causes, and manifestations.Radiographics201737256257610.1148/rg.201716008528165876
    [Google Scholar]
  6. MillerA.H. HaroonE. RaisonC.L. FelgerJ.C. Cytokine targets in the brain: Impact on neurotransmitters and neurocircuits.Depress. Anxiety201330429730610.1002/da.2208423468190
    [Google Scholar]
  7. BonaviaL. McOwanB. JacksonJ. Cytotoxic lesion of the corpus callosum in a case of Q fever.J. Clin. Neurosci.20221041626310.1016/j.jocn.2022.08.00435964404
    [Google Scholar]
  8. TakanashiJ. Two newly proposed infectious encephalitis/encephalopathy syndromes.Brain Dev.200931752152810.1016/j.braindev.2009.02.01219339128
    [Google Scholar]
  9. ZhuY. ZhengJ. ZhangL. ZengZ. ZhuM. LiX. LouX. WanH. HongD. Reversible splenial lesion syndrome associated with encephalitis/encephalopathy presenting with great clinical heterogeneity.BMC Neurol.20161614910.1186/s12883‑016‑0572‑927089920
    [Google Scholar]
  10. TetsukaS. Reversible lesion in the splenium of the corpus callosum.Brain Behav.2019911e0144010.1002/brb3.144031588684
    [Google Scholar]
  11. CoolenT. LolliV. SadeghiN. RovaiA. TrottaN. TacconeF.S. CreteurJ. HenrardS. GoffardJ.C. DewitteO. NaeijeG. GoldmanS. De TiègeX. Early postmortem brain MRI findings in COVID-19 non-survivors.Neurology20209514e2016e202710.1212/WNL.000000000001011632546654
    [Google Scholar]
  12. KuboM. KuboK. KobayashiK. KomiyaN. Non-severe COVID-19 complicated by cytotoxic lesions of the corpus callosum (mild encephalitis/encephalopathy with a reversible splenial lesion): A case report and literature review.Int. J. Infect. Dis.202212511910.1016/j.ijid.2022.09.00936122669
    [Google Scholar]
  13. MaedaM. TsukaharaH. TeradaH. NakajiS. NakamuraH. ObaH. IgarashiO. ArasakiK. MachidaT. TakedaK. TakanashiJ.I. Reversible splenial lesion with restricted diffusion in a wide spectrum of diseases and conditions.J. Neuroradiol.200633422923610.1016/S0150‑9861(06)77268‑617041527
    [Google Scholar]
  14. GaurP. DixonL. JonesB. LyallH. JanW. COVID-19-associated cytotoxic lesions of the corpus callosum.AJNR Am. J. Neuroradiol.202041101905190710.3174/ajnr.A671332819904
    [Google Scholar]
  15. GoenkaA.H. MukundA. AhujaJ. KumarA. Reversible lesion in the splenium of the corpus callosum in a child with influenza-associated encephalitis–encephalopathy (IAEE).J. Clin. Neurosci.2010175607, 67810.1016/j.jocn.2009.07.09320358640
    [Google Scholar]
  16. OharaH. ShimizuH. KasamatsuT. KajitaA. UnoK. LaiK.W. VellingiriB. SugieK. KinoshitaM. Cytotoxic lesions of the corpus callosum after COVID-19 vaccination.Neuroradiology202264102085208910.1007/s00234‑022‑03010‑y35809100
    [Google Scholar]
/content/journals/cmir/10.2174/1573405620666230414110124
Loading
/content/journals/cmir/10.2174/1573405620666230414110124
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test